THE Therapeutic Goods Administration has published a response to the Vitamania documentary broadcast last Sun (PD 06 Aug), with the aim of providing context around how the TGA regulates vitamins in Australia.
"We assess lower risk medicines for safety and quality only...however the commercial sponsor of the medicine is required to hold evidence that their product works, and they must provide this evidence to the TGA if we conduct a formal compliance review of the product," the response states.
The TGA noted that this approach reduces the cost of approving low-risk medicines which would otherwise be passed onto consumers - see tga.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 16 Aug 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Aug 18
